2 Firms Build $2.4B Sale Of SF Biopharmaceutical Biz
Pharmaceutical giant Eli Lilly & Co. on Tuesday announced that it has agreed to purchase San Francisco-based biopharmaceutical company Dice Therapeutics in a deal totaling roughly $2.4 billion and built by...To view the full article, register now.
Already a subscriber? Click here to view full article